Picture of Immunovia AB (publ) logo

IMMNOV Immunovia AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Immunovia Gets Approval To Begin Testing Patients For Pancreatic Cancer With Immray Pancan-D Test

Aug 4 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA, INC. RECEIVES APPROVAL TO BEGIN TESTING
PATIENTS FOR
PANCREATIC CANCER WITH THE IMMRAY™ PANCAN-D TEST
    * THIS APPROVAL WAS RECEIVED FROM MASSACHUSETTS DEPARTMENT
OF
PUBLIC HEALTH ON AUGUST 3, 2021

Source text for Eikon:  ID:nWkr413B8k 
Further company coverage:  IMMNOV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Immunovia AB (publ)

See all news